Inhibikase Therapeutics’s (IKT) 10-Day exponential moving average is 1.61, while Inhibikase Therapeutics’s (IKT) share price is $1.65, making it a Buy.
Inhibikase Therapeutics’s (IKT) 100-Day exponential moving average is 1.64, while Inhibikase Therapeutics’s (IKT) share price is $1.65, making it a Buy.
Inhibikase Therapeutics’s (IKT) stock price is $1.65 and Inhibikase Therapeutics’s (IKT) 50-day simple moving average is 1.55, creating a Buy signal.
Inhibikase Therapeutics’s (IKT) stock price is $1.65 and Inhibikase Therapeutics’s (IKT) 100-day simple moving average is 1.61, creating a Buy signal.
Inhibikase Therapeutics’s (IKT) stock price is $1.65 and Inhibikase Therapeutics’s (IKT) 200-day simple moving average is 1.79, creating a Sell signal.